The guideline authors developed more than 10 recommendations with the goal of promoting high-quality, high-value, evidence-based care for adult patients with moderate to severe ulcerative colitis.
Ulcerative colitis (UC) is a risk factor for colorectal cancer (CRC), but authors of a new study evaluated whether patients with UC are still at greater risk for CRC and CRC-related mortality even after the...
Edward Barnes, MD, MPH, discussed practical implications to consider when positioning medications in the management of IBD during his presentation at the Advances in Inflammatory Bowel Diseases Regional in...
Edward Barnes, MD, MPH, discussed practical implications to consider when positioning medications in the management of IBD during his presentation at the Advances in Inflammatory Bowel Diseases Regional in...
Stephen Hanauer, MD, from Northwestern Medicine, discussed key windows of opportunity for effective management of Crohn disease during his presentation at the Advances in Inflammatory Bowel Diseases...
Researchers evaluated data on more than 17,000 individuals with an autoimmune disease who received treatment with an anti-tumor necrosis factor α agent to determine the risk of developing new inflammatory...
Researchers evaluated data on more than 17,000 individuals with an autoimmune disease who received treatment with an anti-tumor necrosis factor α agent to determine the risk of developing new inflammatory...
Patients with inflammatory bowel disease have an increased risk for venous thromboembolism during hospitalization. Researchers in Ontario, Canada, sought to determine whether the risk continues after...
Researchers analyzed results of the REACT clinical trial to determine whether age affects the safety and efficacy of early combined immunosuppressive treatment in Crohn disease.
The American Gastroenterological Association has published new recommendations on which therapies are best for the management of mild-to-moderate ulcerative colitis.
